Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
J Obstet Gynaecol ; 40(8): 1102-1105, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32270724

RESUMO

We aimed to investigate whether proteinuria in the first trimester of pregnancy in Familial Mediterranean fever (FMF) patients has an impact on pregnancy outcome and perinatal and neonatal outcome of pregnancies. A total of 66 pregnant with FMF were compared with healthy controls at the same gestational weeks. Patients with FMF had a higher antenatal hospitalisation rate (34.8% vs. 6.1%, respectively, p < .01) and higher rate of 2 or more miscarriages. FMF patients with or without obstetric complications also had a similar amount of 24-h urine proteinuria in the first trimester. Patients on colchicine therapy during pregnancy had more frequent attacks in pregnancy (59.3% vs. 18.2%, respectively, p: .012). The rates of preeclampsia, preterm delivery, foetal anomalies, small for gestation age neonates and primary caesarean rate were similar between groups. In conclusion; FMF had no significant impact on pregnancy. Neither attacks in pregnancy nor basal proteinuria were associated with adverse outcomes.Impact statementWhat is already known on this subject? Familial Mediterranean fever (FMF) is an autosomal recessive disease characterised by inflammation of the serosal, synovial and cutaneous tissues with recurrent attacks. One of the most serious complications of FMF is amyloidosis that can cause end-stage renal disease. Outcomes of FMF on pregnancy have been analysed by only few studies. Amyloidosis based on the initial renal function may adversely affect pregnancies. It has been reported that FMF patients with renal amyloidosis may suffer pregnancy complications to a greater extent.What do the results of this study add? There have been few studies on the correlation between FMF, proteinuria and pregnancy outcomes. In our study we found that FMF had no significant impact on pregnancy. Neither attacks in pregnancy nor basal proteinuria were associated with adverse outcomes.What are the implications of these findings for clinical practice and/or further research? Our study suggested that FMF had no relationship between pregnancy outcomes. However, our study population is relatively small. It will contribute to comprehensive studies involving a larger population. Future studies should be performed to investigate the effects of basal proteinuria in pregnancy with FMF.


Assuntos
Febre Familiar do Mediterrâneo/complicações , Complicações na Gravidez/epidemiologia , Resultado da Gravidez/epidemiologia , Primeiro Trimestre da Gravidez/urina , Proteinúria/complicações , Adulto , Amiloidose/complicações , Amiloidose/congênito , Estudos de Casos e Controles , Cesárea/estatística & dados numéricos , Colchicina/uso terapêutico , Anormalidades Congênitas , Febre Familiar do Mediterrâneo/urina , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Recém-Nascido , Recém-Nascido Pequeno para a Idade Gestacional , Nefropatias/complicações , Nefropatias/congênito , Pré-Eclâmpsia/epidemiologia , Pré-Eclâmpsia/etiologia , Gravidez , Complicações na Gravidez/urina , Nascimento Prematuro/epidemiologia , Nascimento Prematuro/etiologia , Proteinúria/congênito
2.
J Cutan Pathol ; 47(4): 406-408, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31721261

RESUMO

Exogenous insulin amyloidosis (AIns) is an iatrogenic form of amyloidosis which is found in diabetic patients, generally localized to the site of subcutaneous insulin administration. It may form a discrete mass that could come to clinical attention, and can contribute to abnormal pharmacokinetics of the exogenous insulin, resulting in worsened control of diabetes. In this case report, we describe such a lesion in a 72-year-old man with a history of type 2 diabetes and primary adrenal gland epithelioid sarcoma and discuss the diagnostic challenges it poses.


Assuntos
Parede Abdominal/patologia , Neoplasias das Glândulas Suprarrenais , Amiloidose , Diabetes Mellitus Tipo 2 , Insulina , Sarcoma , Neoplasias das Glândulas Suprarrenais/metabolismo , Neoplasias das Glândulas Suprarrenais/patologia , Idoso , Amiloidose/congênito , Amiloidose/metabolismo , Amiloidose/patologia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/patologia , Humanos , Injeções Subcutâneas , Insulina/administração & dosagem , Insulina/efeitos adversos , Masculino , Metástase Neoplásica , Sarcoma/metabolismo , Sarcoma/patologia
3.
Herz ; 38(1): 93-6, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22842809

RESUMO

Takayasu arteritis (TA) is a chronic granulomatous panarteritis, predominantly affecting the aorta and its main branches. Infections, genetic factors as suggested by familial clustering, and autoimmunity may play a role in its pathogenesis. In this report, we describe familial TA in a mother and daughter with diverse clinical manifestations. In addition to being a familial form of vasculitis, both of our cases demonstrated amyloidosis, chronic renal disease thought to be due to ischemic nephropathy, and hypertensive nephrosclerosis.


Assuntos
Amiloidose/congênito , Amiloidose/diagnóstico , Insuficiência Renal Crônica/congênito , Insuficiência Renal Crônica/diagnóstico , Arterite de Takayasu/congênito , Arterite de Takayasu/diagnóstico , Adulto , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Núcleo Familiar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...